Col4a1 mutations cause progressive retinal neovascular defects and retinopathy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Alavi, Marcel V ^a   Mao, Mao ^a   Pawlikowski, Bradley T ^a,e   Kvezereli, Manana ^a   Duncan, Jacque L ^a   Libby, Richard T ^b   John, Simon W M ^c   Gould, Douglas B ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4;

ANIMAL; DISEASE COURSE; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; MUTATION; OPHTHALMOSCOPE; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PHENOTYPE; RETINA; RETINAL DISEASES; ULTRASTRUCTURE;

ANIMALS; COLLAGEN TYPE IV; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; MICE; MICE, KNOCKOUT; MUTATION; OPHTHALMOSCOPES; PHENOTYPE; RETINA; RETINAL DISEASES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84955585163     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18602     Document Type: Article

References (54)

1. Campochiaro, P. A. Ocular neovascularization. J Mol Med (Berl) 91, 311-321 (2013).
2. Gould, D. B. et al. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science 308, 1167-1171 (2005).
3. Gould, D. B. et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 354, 1489-1496 (2006).
4. Plaisier, E. et al. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med 357, 2687-2695 (2007).
5. Kuo, D. S., Labelle-Dumais, C., Gould, D. B. COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet 21, R97-110 (2012).
6. Sado, Y. et al. Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different alpha chains of human type IV collagen. Histochem Cell Biol 104, 267-275 (1995).
7. Uechi, G., Sun, Z., Schreiber, E. M., Halfter, W., Balasubramani, M. Proteomic View of Basement Membranes from Human Retinal Blood Vessels, Inner Limiting Membranes, and Lens Capsules. J Proteome Res 13, 3693-3705 (2014).
8. Chen, L., Miyamura, N., Ninomiya, Y., Handa, J. T. Distribution of the collagen IV isoforms in human Bruch's membrane. Br J Ophthalmol 87, 212-215 (2003).
9. Bai, X., Dilworth, D. J., Weng, Y. C., Gould, D. B. Developmental distribution of collagen IV isoforms and relevance to ocular diseases. Matrix Biol 28, 194-201 (2009).
10. Khoshnoodi, J., Cartailler, J. P., Alvares, K., Veis, A., Hudson, B. G. Molecular recognition in the assembly of collagens: terminal noncollagenous domains are key recognition modules in the formation of triple helical protomers. J Biol Chem 281, 38117-38121 (2006).
11. Tsilibary, E. C., Charonis, A. S. The role of the main noncollagenous domain (NC1) in type IV collagen self-assembly. J Cell Biol 103, 2467-2473 (1986).
12. Mao, M., Alavi, M. V., Labelle-Dumais, C., Gould, D. B. Type IV Collagens and Basement Membrane Diseases: Cell Biology and Pathogenic Mechanisms. in Current Topics in Membranes, Vol. 76, 61-116 (2015).
13. Gould, D. B., Marchant, J. K., Savinova, O. V., Smith, R. S., John, S. W. Col4a1 mutation causes endoplasmic reticulum stress and genetically modifiable ocular dysgenesis. Hum Mol Genet 16, 798-807 (2007).
14. Van Agtmael, T. et al. Dominant mutations of Col4a1 result in basement membrane defects which lead to anterior segment dysgenesis and glomerulopathy. Hum Mol Genet 14, 3161-3168 (2005).
15. Jeanne, M., Jorgensen, J., Gould, D. B. Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention. Circulation 131, 1555-1565 (2015).
16. Mao, M. et al. Strain Dependent Anterior Segment Dysgenesis and Progression to Glaucoma in Col4a1 Mutant Mice. Invest Ophthalmol Vis Sci 56, 6823-6831 (2015).
17. Favor, J. et al. Type IV procollagen missense mutations associated with defects of the eye, vascular stability, the brain, kidney function and embryonic or postnatal viability in the mouse, Mus musculus: an extension of the Col4a1 allelic series and the identification of the first two Col4a2 mutant alleles. Genetics 175, 725-736 (2007).
18. Kuo, D. S. et al. Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations. Hum Mol Genet 23, 1709-1722 (2014).
19. Spaide, R. F., Curcio, C. A. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina 31, 1609-1619 (2011).
20. Labelle-Dumais, C. et al. COL4A1 mutations cause ocular dysgenesis, neuronal localization defects, and myopathy in mice and Walker-Warburg syndrome in humans. PLoS Genet 7, e1002062 (2011).
21. Bai, Y. et al. Muller cell-derived VEGF is a significant contributor to retinal neovascularization. J Pathol 219, 446-454 (2009).
22. Iacovelli, J. et al. Generation of Cre transgenic mice with postnatal RPE-specific ocular expression. Invest Ophthalmol Vis Sci 52, 1378-1383 (2011).
23. Braren, R. et al. Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol 172, 151-162 (2006).
24. Thanos, A. et al. Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse. Am J Pathol 180, 1917-1927 (2012).
25. Hartnett, M. E., Weiter, J. J., Staurenghi, G., Elsner, A. E. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 103, 2042-2053 (1996).
26. Yannuzzi, L. A. et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 21, 416-434 (2001).
27. Viola, F., Massacesi, A., Orzalesi, N., Ratiglia, R., Staurenghi, G. Retinal angiomatous proliferation: natural history and progression of visual loss. Retina 29, 732-739 (2009).
28. Sigler, E. J., Calzada, J. I. Retinal Angiomatous Proliferation with Chorioretinal Anastomosis in Childhood Coats Disease: A Reappraisal of Macular Fibrosis Using Multimodal Imaging. Retina 35, 537-546 (2015).
29. Gilmour, D. F. Familial exudative vitreoretinopathy and related retinopathies. Eye (Lond) 29, 1-14 (2015).
30. Freund, K. B. et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 28, 201-211 (2008).
31. Hasegawa, E. et al. Characterization of a spontaneous retinal neovascular mouse model. PLoS One 9, e106507 (2014).
32. Hu, W. et al. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation. Invest Ophthalmol Vis Sci 49, 407-415 (2008).
33. Li, C. et al. Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation. Arch Ophthalmol 125, 795-803 (2007).
34. Nagai, N. et al. Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunction. Invest Ophthalmol Vis Sci 55, 3709-3719 (2014).
35. Xia, C. H., Yablonka-Reuveni, Z., Gong, X. LRP5 is required for vascular development in deeper layers of the retina. PLoS One 5, e11676 (2010).
36. Chen, Y., Hu, Y., Lu, K., Flannery, J. G., Ma, J. X. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization. J Biol Chem 282, 34420-34428 (2007).
37. Multhaupt, H. A. et al. Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry. Am J Pathol 148, 1985-1997 (1996).
38. Ye, X. et al. Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell 139, 285-298 (2009).
39. Sudhakar, A. et al. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. J Clin Invest 115, 2801-2810 (2005).
40. Rebustini, I. T. et al. MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis. Dev Cell 17, 482-493 (2009).
41. Knighton, D. R. et al. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221, 1283-1285 (1983).
42. Kelly, B. D. et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93, 1074-1081 (2003).
43. Yamakawa, M. et al. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93, 664-673 (2003).
44. Carmeliet, P. et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7, 575-583 (2001).
45. Feeney, S. A. et al. Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression. Invest Ophthalmol Vis Sci 44, 839-847 (2003).
46. Sakurai, E., Anand, A., Ambati, B. K., van Rooijen, N., Ambati, J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44, 3578-3585 (2003).
47. Nishimura, T., Goodnight, R., Prendergast, R. A., Ryan, S. J. Activated macrophages in experimental subretinal neovascularization. Ophthalmologica 200, 39-44 (1990).
48. Kruegel, J., Rubel, D., Gross, O. Alport syndrome-insights from basic and clinical research. Nat Rev Nephrol 9, 170-178 (2013).
49. Savige, J. et al. Retinal basement membrane abnormalities and the retinopathy of Alport syndrome. Invest Ophthalmol Vis Sci 51, 1621-1627 (2010).
50. Vahedi, K., Alamowitch, S. Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease. Curr Opin Neurol 24, 63-68 (2011).
51. Shah, S. et al. Childhood presentation of COL4A1 mutations. Dev Med Child Neurol 54, 569-574 (2012).
52. Kowalczuk, L. et al. Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy. PLoS One 6, e17462 (2011).
53. Zenteno, J. C. et al. Next generation sequencing uncovers a missense mutation in COL4A1 as the cause of familial retinal arteriolar tortuosity. Graefes Arch Clin Exp Ophthalmol 252, 1789-1794 (2014).
54. Wang, F., Wang, J., Liu, D., Su, Y. Normalizing genes for real-time polymerase chain reaction in epithelial and nonepithelial cells of mouse small intestine. Anal Biochem 399, 211-217 (2010).